Schizophrenia News

Adults with cerebral palsy, particularly those with neurodevelopmental disorders, have increased risk for mental health disorders compared with adults without cerebral palsy, according to a study published in the Annals of Internal Medicine.

Using a human-centered design that includes providers’ input could help optimize guideline-based prescribing of antipsychotics for young people, researchers wrote in Psychiatric Services.

Transdermal estradiol was an effective add-on treatment for women with schizophrenia, particularly those aged older than 38 years, findings published in JAMA Psychiatry showed.

For the prevention of infanticide and suicide in the postpartum period, experts wrote that inpatient care — preferably at a mother-infant unit — is vital to guarantee safety, complete the diagnostic evaluation and initiate treatment.

Clozapine was linked to an 18% lower risk for hospitalization and 27% lower risk for all-cause discontinuation compared with nonclozapine second-generation antipsychotics, despite greater illness severity in patients with schizophrenia receiving clozapine, according to findings from a meta-analysis of cohort studies.

Approximately half of youth who received antipsychotics during the year after an ADHD diagnosis had a diagnosis for which antipsychotics are indicated, and less than half of these youth received a stimulant — the evidence-supported first-line ADHD treatment, study data revealed.

Massachusetts General Hospital has been named the number one hospital for psychiatric care in America for 2019 to 2020, according to the U.S. News & World Report.

The potential of artificial intelligence and machine learning approaches to identify mental illness continues to be exciting area of research.

Adults with schizophrenia and other psychoses continue to experience cognitive decline after illness onset; however, the nature of this decline differs across neuropsychological functions, according to data from a 10-year prospective study published in American Journal of Psychiatry.

The nicotinate phosphoribosyltransferase gene, or NAPRT1, was identified as a novel susceptibility gene for schizophrenia, according to data from an Indian genome-wide association study.